Responses
Clinical/translational cancer immunotherapy
Original research
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.
